First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001‐2012

The aim of this study was to assess the outcome of patients with aplastic anemia (AA), receiving rabbit anti‐thymocyte globulin (Thymoglobulin, SANOFI) and cyclosporin, as first line treatment. Eligible were 955 patients with AA, treated first line with Thymoglobulin, between 2001 and 2008 (n = 492)...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacigalupo, Andrea, Oneto, Rosi, Schrezenmeier, Hubert, Hochsmann, Britta, Dufour, Carlo, Kojima, Seiji, Zhu, Xiaofan, Chen, Xiaojuan, Issaragrisil, Surapol, Chuncharunee, Suporn, Jeong, Dae Chul, Giammarco, Sabrina, Van Lint, Maria Teresa, Zheng, Yizhou, Vallejo, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667908/
https://www.ncbi.nlm.nih.gov/pubmed/29498107
http://dx.doi.org/10.1002/ajh.25081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667908/
https://www.ncbi.nlm.nih.gov/pubmed/29498107
http://dx.doi.org/10.1002/ajh.25081

Ejemplares similares